RxDoctor Payments Data

William Buice, MD

Surgery · Anderson, SCNPI 1982658837

Payments from drug & device makers

$3,599in general payments, 2019–2025

Across 168 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$266
  • Eisai Inc.$217
  • AstraZeneca$195
  • Johnson & Johnson$149
  • Novartis$143
  • Boston Scientific$125
  • plus $2K from 54 others

What the payments were for

  • Food & beverage$3,588100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck11$266
Eisai Inc.10$217
AstraZeneca(2 entities)11$195
Johnson & Johnson(2 entities)9$149
Novartis7$143
Boston Scientific2$125
Medical Device Business Services, Inc.1$116
Davol Inc.3$109
Incyte Corporation6$105
Seagen Inc.6$98
Focal Therapeutics, Inc.1$94
Bristol Myers Squibb4$90
BD4$89
Amgen5$85
Atricure, Inc.1$73
Jazz Pharmaceuticals Inc.4$71
Daiichi Sankyo Inc.3$69
Molli Surgical (US) Inc1$64
Pacira Pharmaceuticals Incorporated4$63
Regeneron Healthcare Solutions, Inc.2$57
Heron Therapeutics, Inc.3$56
Smith+Nephew3$54
Takeda Pharmaceuticals U.S.A., Inc.3$48
Ipsen Biopharmaceuticals, Inc2$47
Ferring Pharmaceuticals Inc.2$44
Medtronic2$39
Blueprint Medicines Corporation2$38
Pharmacyclics LLC, An Abbvie Company3$38
Rigel Pharmaceuticals, Inc.2$35
Lemaitre Vascular, Inc.2$34
Solventum Corporation2$31
Merit Medical Systems Inc2$30
Coherus Oncology, Inc.2$30
TELA Bio, Inc.1$30
Axonics, Inc.1$29
Stemline Therapeutics Inc.1$29
Adaptive Biotechnologies Corporation1$24
Deciphera Pharmaceuticals Inc.1$24
Caris MPI, Inc.1$24
G1 Therapeutics, Inc.1$24
Innovation Technologies Inc1$23
Convatec Inc.1$23
W. L. Gore & Associates, Inc.1$23
AbbVie1$22
Polynovo North America LLC1$22
Genentech USA, Inc.1$22
Bard Access Systems, Inc.1$21
Exelixis Inc.1$21
Geron Corporation1$20
Springworks Therapeutics, Inc.1$19
ADC Therapeutics America, Inc.1$19
Eagle Pharmaceuticals, Inc.1$19
Teleflex LLC1$19
Acrotech Biopharma Inc.1$19
Myriad Genetic Laboratories, Inc.1$18
Epizyme, Inc.1$18
EMD Serono, Inc.1$16
AVEO Pharmaceuticals, Inc.1$16
Lilly USA, LLC1$16
Medela LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,599 in reported general payments places this provider in the 65th percentile of 553 surgery providers in South Carolina.

See all surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$101,454
Medicare patients
233
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl102$173
Doxycycline Hyclate11$67

Paid to pharmacies, not to this prescriber.

Other surgery in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →